Morningstar

CME Group's Terry Duffy to Step Down as CEO; Lynne Fitzpatrick to Take Helm

Provided by Dow Jones

By Colin Kellaher 




  CME Group's longtime leader, Terry Duffy, plans to step down as chief executive of the derivatives marketplace early next year. 



  CME Group on Wednesday said Duffy, who has been chairman of the Chicago company since 2002 and CEO since 2016, will hand the reins to Lynne Fitzpatrick, currently president and chief financial officer, on March 1, 2027. 



  Duffy, who joined CME Group as a runner in the lean hog pit in 1980, will become executive chairman on that date, and Fitzpatrick will join the board, the company said. 



  Fitzpatrick, 48 years old, joined CME Group in 2006 and has been chief financial officer since 2023 and president since 2024. 



  The company said it will initiate a search of potential candidates to succeed Fitzpatrick as finance chief. 





  Write to Colin Kellaher at colin.kellaher@wsj.com 





  (END) Dow Jones Newswires



  June 17, 2026 09:04 ET (13:04 GMT)


Copyright (c) 2026 Dow Jones & Company, Inc.
  

					The articles, information, and content displayed on this webpage may
					include materials prepared and provided by third parties. Such
					third-party content is offered for informational purposes only and
					is not endorsed, reviewed, or verified by Morningstar.
				
 

					Morningstar makes no representations or warranties regarding the
					accuracy, completeness, timeliness, or reliability of any third-party
					content displayed on this site. The views and opinions expressed in
					third-party content are those of the respective authors and do not
					necessarily reflect the views of Morningstar, its affiliates, or employees.
				
 

					Morningstar is not responsible for any errors, omissions, or delays
					in this content, nor for any actions taken in reliance thereon.
					Users are advised to exercise their own judgment and seek independent
					financial advice before making any decisions based on such content.
					The third-party providers of this content are not affiliated with
					Morningstar, and their inclusion on this site does not imply any
					form of partnership, agency, or endorsement.
				
 

				Popular
				
 
  
 
 
 
 
5 Stocks to Buy Trading at Big Discounts
 
Plus, what recent bond market volatility means for investors. 
 
 
David Sekera, CFA and Sarah Hansen 
 
 
 
2 Undervalued Stocks to Buy With Long-Term Growth Ahead
 
Defense spending and booming data center demand could provide powerful tailwinds for these 4-star stocks. 
 
 
David Sekera, CFA, Sarah Hansen, and Jess Bebel 
 
 
 
The Market May Be Too Pessimistic About This 4-Star Dividend Stock
 
Despite a looming patent cliff, a strong drug pipeline and 4.1% yield give investors reasons for optimism. 
 
 
Karen Andersen, CFA 
 
 
 
4 Stocks to Buy for the Long-Term While They’re Still Undervalued
 
Plus, a deep dive on SpaceX’s bid to challenge US telecoms. 
 
 
David Sekera, CFA and Sarah Hansen 
 
 
 
There Are Three Paths Forward for the AI Boom. Two of Them Lead to Lower Interest Rates
 
Mass layoffs or a spending slowdown would likely require hefty Fed rate cuts. 
 
 
Preston Caldwell 
 
 
 
 

			Sponsor Center